# The ATTRibute-CM Trial

An episode of [Talking Points](https://invisiblenetwork.ai/podcast/1093943397), 4 Sep 2024, 6:52.

Audio: https://feeds.soundcloud.com/stream/1910068403-user-842180102-237361060-the-attribute-cm-trial.mp3

Julian Gillmore and C. Michael Gibson discuss the efficacy of acoramidis for patients with transthyretin amyloid cardiomyopathy.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.